Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Rapamycin reverses deficits in tuberous sclerosis model

Aug. 14, 2008

AMPK agonist enhances exercise endurance without exercise training

Aug. 14, 2008

New analgesic agents revealed in recent patents

Aug. 13, 2008

FDA accepts Pain Therapeutics' NDA for Remoxy and grants priority review

Aug. 13, 2008

Reduction of CSF biomarkers with PBT-2 treatment in phase II study

Aug. 13, 2008

Preclinical data on memogain, a galantamine prodrug, reported by Galantos

Aug. 12, 2008

Santhera provides update on idebenone for the treatment of Friedreich's ataxia

Aug. 12, 2008

Innocoll completes dosing in phase II clinical trial of CollaRx in postoperative pain

Aug. 11, 2008

Novel vitamin/nutriceutical formulation improves cognitive decline and behavioral symptoms

Aug. 11, 2008

Studies in vitro, in vivo display activity of gamma-secretase inhibitor GSI-953

Aug. 11, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...